You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Terns Pharmaceuticals
since
auto-detected in 1 stories
20 days ago
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
page 1 of 1